INHALED NITRIC OXIDE IN THE ACUTE TREATMENT OF SICKLE CELL DISEASE PAIN CRISIS

吸入一氧化氮治疗镰状细胞病疼痛危机的急性治疗

• 批准号: 7607282
• 负责人: DEBRA KAYE WEINER
• 金额: $ 1.81万
• 依托单位: BOSTON CHILDREN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2008-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7607282
• 关键词: Acute; Breathing; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Institution; Nitric Oxide; Pain; Patients; Research; Research Personnel; Resources; Safety; Sickle Cell Anemia; Source; United States National Institutes of Health; inhaled nitric oxide

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The objective of this study is to determine the safety and efficacy of nitric oxide for inhalation in the treatment of vaso-occlusive pain crisis (VOC) in patients with sickle cell disease.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目和 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 本研究的目的是确定吸入一氧化氮治疗镰状细胞病患者血管闭塞性疼痛危象 (VOC) 的安全性和有效性。